Publication | Closed Access

Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation

Novel Cationic PolyNanomedicineMedicinal ChemistryDrug TargetingEngineeringPolymer-drug ConjugateMedicinePharmaceutical NanotechnologyMultidrug ResistanceNano-drug DeliveryBiomedical EngineeringDrug Delivery SystemPharmacologyDrug DiscoveryDrug Resistance